Jason Waithman

Associate Professor Jason Waithman leads the Cancer Immunotherapy Program at the University of Western Australia's School of Biomedical Sciences. His expertise spans dendritic cell biology, T cell immunity, and cancer immunology. He holds dual affiliations with the School of Human Sciences and the Australian Centre for RNA Therapeutics in Cancer.

Education: PhD in Immunology (University of Melbourne, 2008), specializing in CD8 T cell tolerance mechanisms.

Research focuses on translational immunotherapy tools, genomic data science integration, and identifying novel therapeutic targets for cancer control. Key projects include CAR-T cell therapy optimization, immune response modulation in melanoma, and burn injury's impact on cancer immunity.

Recent grants include leadership roles in skin cancer classification probes, high-content microscopy infrastructure, and natural killer cell enhancement therapies. He has authored 56 publications and 24 grants, with 4,513 citations and a h-index of 25.

Labs/Teams: Cancer Immunotherapy Program, Australian Centre for RNA Therapeutics in Cancer. Collaborations span international institutions with a focus on immunology and oncology.